CPA-7

Overview

CPA7 is a novel Stat3 inhibitor. CPA7 downregulates survivin , Bcl-XL , and Mcl-1 . CPA7 induces Apoptosis . CPA7 enhances the radiosensitivity of prostate cancer . CPA7 has anti-cancer effects against prostate cancer .

Application

Products | Products > Disease Areas > Cancer | Products > Signaling Pathways > JAK/STAT Signaling | Products > Signaling Pathways > Stem Cell/Wnt | Products > Signaling Pathways > Apoptosis | Products > Research Areas > Cancer | Products > Research Areas > Cancer > Cancer Targeted Therapy | Products > Research Areas > Cancer > Cancer Immunotherapy | Products > Research Areas > Cancer > Cancer Stem Cells | Products > Research Areas > Cancer > Cancer Metabolism and Metastasis | Products > Signaling Pathways > STAT | Products > Signaling Pathways > Survivin | Products > Signaling Pathways > Bcl-2 Family | Products > Signaling Pathways > Apoptosis

Product Information

• Catalog No.: HY-122759
• CAS No.: 16961-77-6
• Molecular Formula: Cl3H6N3O2Pt
• Molecular Weight: 381.51
• Purity: 99.98%
• Storage: Please store the product under the recommended conditions in the Certificate of Analysis.

Source

Original product source